Clinical trials: Sepsis - to Reduce Mortality in the Intensive Care Unit
Sepsis - to Reduce Mortality in the Intensive Care Unit
Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality
Procalcitonin, a marker of infection has often been compared to clinical pictures as for instance "clinical sepsis". This has given som problems in the interpretation of these studies, because of the lack of good Gold Standards…
- Trial name
- NCT00144638
- Where
- Denmark
- Volunteers
- 450 people
- Sponsor
- Danish Procalcitonin Study Group